We are live on
!
Find out more
CCM
Convector Capital Management Portfolio holdings
AUM
$54.5M
1-Year Est. Return
11.63%
This Fund
S&P 500
This Quarter
Est. Return
-2.39%
1 Year Est. Return
+11.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
-$26.4M
(-27%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-32.12%
Top 10 Holdings %
Top 10 Hldgs %
56.93%
Holding
37
New
5
Increased
3
Reduced
20
Closed
7
Top Buys
| 1 |
Chevron
CVX
|
+$2.48M |
| 2 |
Liberty Global Class A
LBTYA
|
+$2.27M |
| 3 |
Bausch Health
BHC
|
+$1.9M |
| 4 |
Procter & Gamble
PG
|
+$1.48M |
| 5 |
JPMorgan Chase
JPM
|
+$1.25M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$4.09M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$3.91M |
| 3 |
Apple
AAPL
|
+$3.81M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$3.1M |
| 5 |
AET
Aetna Inc
AET
|
+$2.25M |
Sector Composition
| 1 | Technology | 22.35% |
| 2 | Healthcare | 21.61% |
| 3 | Industrials | 10.46% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Energy | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$169B
| $5.84M | 8.06% |
70,000
-46,050
| -40% | -$4.09M |
|
|
2
Apple
AAPL
$4.89T
| $5.26M | 7.26% |
220,000
-153,304
| -41% | -$3.81M |
|
3
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $4.48M | 6.19% |
21,400
| – | – |
|
4
Qorvo
QRVO
$7.37B
| $4.07M | 5.62% |
73,700
-18,700
| -20% | -$935K |
|
|
5
Bausch Health
BHC
$1.84B
| $3.87M | 5.34% |
192,000
+67,000
| +54% | +$1.9M |
|
|
LL
6
DELISTED
LL Flooring Holdings, Inc.
LL
| $3.76M | 5.19% |
244,000
-15,400
| -6% | -$214K |
|
7
Qualcomm
QCOM
$180B
| $3.75M | 5.18% |
70,000
-40,000
| -36% | -$2.11M |
|
|
YHOO
8
DELISTED
Yahoo Inc
YHOO
| $3.52M | 4.85% |
93,600
-40,100
| -30% | -$1.48M |
|
|
9
Procter & Gamble
PG
$353B
| $3.38M | 4.66% |
39,885
+18,000
| +82% | +$1.48M |
|
10
United Airlines
UAL
$38.6B
| $3.32M | 4.59% |
81,000
-27,000
| -25% | -$1.28M |
|
11
Babcock & Wilcox
BW
$1.49B
| $3.17M | 4.37% |
8,860
-254
| -3% | -$54.2K |
|
12
Cisco
CSCO
$432B
| $3.11M | 4.3% |
108,500
-7,000
| -6% | -$196K |
|
|
MNK
13
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.8M | 3.86% |
46,000
-64,000
| -58% | -$3.91M |
|
|
14
Chevron
CVX
$366B
| $2.59M | 3.57% |
+24,680
| New | +$2.48M |
|
15
Yum! Brands
YUM
$41.9B
| $2.49M | 3.43% |
41,730
| – | – |
|
|
OA
16
DELISTED
Orbital ATK, Inc.
OA
| $2.44M | 3.36% |
28,608
-2,532
| -8% | -$221K |
|
17
Take-Two Interactive
TTWO
$44.5B
| $2.2M | 3.03% |
57,900
-3,100
| -5% | -$114K |
|
|
18
Liberty Global Class A
LBTYA
$3.63B
| $2.03M | 2.81% |
+70,000
| New | +$2.27M |
|
|
19
JPMorgan Chase
JPM
$912B
| $1.24M | 1.72% |
+20,000
| New | +$1.25M |
|
|
FOLD
20
DELISTED
Amicus Therapeutics
FOLD
| $1.13M | 1.55% |
206,000
-28,400
| -12% | -$199K |
|
|
TIVO
21
DELISTED
Tivo Inc
TIVO
| $1.09M | 1.5% |
69,659
+3,477
| +5% | +$58.4K |
|
22
Capri Holdings
CPRI
$1.94B
| $974K | 1.34% |
19,676
-8,324
| -30% | -$409K |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals
AERI
| $972K | 1.34% |
55,200
-4,800
| -8% | -$77.7K |
|
24
Jefferies Financial Group
JEF
$12.9B
| $953K | 1.32% |
61,442
-5,586
| -8% | -$85.3K |
|
25
Acadia Pharmaceuticals
ACAD
$4.39B
| $886K | 1.22% |
27,300
-33,700
| -55% | -$1.13M |
|
Similar funds
IAM
HPA
EL
KCP
LSVM
BS
CSM
CCG
Convector Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Convector Capital Management held 37 positions worth $72.5M, down 27% from $98.9M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Convector Capital Management withdrew a net $23.3M in Q2 2016, closing 7 positions and reducing 20 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $3.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Convector Capital Management opened a new position in Chevron worth $2.59M.
- Convector Capital Management's largest Q2 2016 buy was Chevron: 24,680 shares worth $2.59M.
- Convector Capital Management added most to Bausch Health in Q2 2016, an estimated $1.9M increase.
- Convector Capital Management's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $4.09M.
- Convector Capital Management fully exited Teva Pharmaceuticals in Q2 2016, selling an estimated $3.1M.
- Convector Capital Management's ten largest holdings make up 57% of its $72.5M portfolio in Q2 2016.
- Convector Capital Management opened 5 new positions and closed 7 in Q2 2016.
- Convector Capital Management's portfolio value fell 27% quarter-over-quarter to $72.5M.
Based on Convector Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.